Valuation: Medistim ASA

Market Cap 519.52Cr 54Cr 49Cr 46Cr 41Cr 78Cr 5.18TCr 78Cr 547.91Cr 213.94Cr 2.69TCr 204.29Cr 199.86Cr 8.64TCr P/E 2026 *
28.6x
P/E 2027 * 26.3x
Enterprise Value 505.72Cr 53Cr 48Cr 44Cr 40Cr 76Cr 5.04TCr 76Cr 533.36Cr 208.26Cr 2.62TCr 198.86Cr 194.56Cr 8.41TCr EV / Sales 2026 *
6.36x
EV / Sales 2027 * 5.81x
Free-Float
79.47%
Yield 2026 *
3.04%
Yield 2027 * 3.15%
1 day-3.17%
1 week+1.48%
Current month+8.70%
1 month+14.58%
3 months+17.52%
6 months+18.53%
Current year+6.18%
1 week 269
Extreme 269
289
1 month 240
Extreme 240
289
Current year 186.5
Extreme 186.5
289
1 year 186.5
Extreme 186.5
292
3 years 130
Extreme 130
292
5 years 130
Extreme 130
402.5
10 years 60
Extreme 60
409
Manager TitleAgeSince
Chief Executive Officer 62 01/09/2009
Director of Finance/CFO - 01/01/2001
Chief Tech/Sci/R&D Officer - 01/01/2025
Director TitleAgeSince
Chairman 78 01/01/2000
Director/Board Member 49 01/01/2014
Director/Board Member 56 01/04/2023
Date Insider Type Main position Quantity % Market Cap. Importance
04/03/25 Buy

Chairman

8,60,735 4.6939%
27/01/25 Buy

Chairman

45,000 0.2454%
09/01/25 Buy

Chairman

30,000 0.1636%
Change 5-day change 1-year change 3-year change Capi.($)
-3.17%+1.48%+20.09%+41.39% 54Cr
+1.53%+1.68%+28.03%+39.42% 25TCr
+0.83%+2.84%+8.99%+7.29% 16TCr
-0.43%+1.38%-3.70%+53.85% 15TCr
-0.72%+3.42%-55.32%-13.17% 6.23TCr
+0.39%+5.10%-14.66%-15.65% 4.96TCr
+1.38%+0.78%+17.84%+22.14% 4.98TCr
-1.42%+5.26%+3.37%+37.59% 4.81TCr
+1.40%+2.90%+26.05%+57.45% 4.91TCr
+1.73%+0.14%+31.06%+72.84% 4.29TCr
Average +0.35%+2.58%+6.17%+30.32% 8.58TCr
Weighted average by Cap. +0.69%+1.95%+8.56%+30.59%

Financials

2026 *2027 *
Net sales 80Cr 8.33Cr 7.49Cr 6.99Cr 6.33Cr 12Cr 792.4Cr 12Cr 84Cr 33Cr 411.26Cr 31Cr 31Cr 1.32TCr 87Cr 9.09Cr 8.17Cr 7.62Cr 6.91Cr 13Cr 864.66Cr 13Cr 91Cr 36Cr 448.76Cr 34Cr 33Cr 1.44TCr
Net income 18Cr 1.9Cr 1.71Cr 1.6Cr 1.45Cr 2.71Cr 180.91Cr 2.73Cr 19Cr 7.47Cr 94Cr 7.14Cr 6.98Cr 301.98Cr 20Cr 2.12Cr 1.9Cr 1.78Cr 1.61Cr 3.02Cr 201.34Cr 3.04Cr 21Cr 8.32Cr 104.5Cr 7.94Cr 7.77Cr 336.09Cr
Net Debt -14Cr -1.45Cr -1.3Cr -1.21Cr -1.1Cr -2.06Cr -137.55Cr -2.08Cr -15Cr -5.68Cr -71Cr -5.43Cr -5.31Cr -229.6Cr -16Cr -1.65Cr -1.48Cr -1.38Cr -1.25Cr -2.36Cr -156.98Cr -2.37Cr -17Cr -6.49Cr -81Cr -6.19Cr -6.06Cr -262.05Cr
Projected Income Statement - Annual - Medistim ASA
Logo Medistim ASA
Medistim ASA is a Norway-based company engaged in the provision of medical equipment and technology. It develops, manufactures and distributes medical devices that measure blood flow and visualize atherosclerosis, and thereby help improve the outcome of cardiac and vascular surgery. The Company provides Transit Time Flow Measurement (TTFM) and ultrasound imaging to the global market to enable medical professionals to reduce risk and enhance quality of cardiac, vascular and transplant surgery. Medistim’s activities are divided into two business units: Own Products Category and Third-Party Products Category. Furthermore, the Company has several subsidiaries, including Medistim USA Inc, Medistim Norge AS and Medistim Japan KK.
Employees
159
Date Price Change Volume
15/26/15 NOK 275.00 -3.17% 5,841
14/26/14 NOK 284.00 -0.35% 11,123
13/26/13 NOK 285.00 +0.71% 10,860
12/26/12 NOK 283.00 +0.71% 15,474
09/26/09 NOK 281.00 +3.69% 24,968
Trader
Investor
Global
Quality
ESG MSCI
-
MarketScreener Ratings - Medistim ASA
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
2
Last Close Price
284.00NOK
Average target price
332.50NOK
Spread / Average Target
+17.08%

Quarterly revenue - Rate of surprise

Rate of surprise - Net sales - Quarterly - Medistim ASA
  1. Stock Market
  2. Stocks
  3. MEDI Stock